ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

117
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bullishCelltrion Pharm
09 Aug 2024 15:34

Targeting Spreads by Leveraging the High Predictability of the Celltrion Merger

This post explores the Celltrion and Celltrion Pharm merger to strategically target swap and appraisal rights spreads by leveraging the merger's...

Logo
250 Views
Share
05 Nov 2023 12:49

Korea Short Sell Ban: Background, Manipulation, Holdings, Flows, Short Interest, Implications

Media reports indicate that there could be a temporary short sell ban in Korea. This could lead to futures backwardation, market manipulation and a...

Logo
1k Views
Share
04 Dec 2024 06:00

KRX Short Interest Weekly (Nov 29th):Korea Zinc, JYP, SK Hynix

We analyzed KRX short interest report for the past week and highlighted short interest changes in Korea Zinc, JYP, SK Hynix.

Logo
274 Views
Share
bearishKum Yang
17 Oct 2024 15:42

Connecting the Dots Between Kum Yang’s Rights Offer & Global Index November Review

This post outlines the current screening status of the Global Index November Review for Korean stocks and explores how it could impact Kum Yang's...

Logo
440 Views
Share
17 Oct 2024 05:50

Korea: Stocks with Potential Passive Flows in November

There could be 1 add and up to 7 deletes from global passive portfolios in Nov. Trackers will need to trade between US$57m to US$230m of the...

Logo
532 Views
Share
x